semaglutide and beta blockers Frailty Effects of in Obesity-Related HFpEF: Findings From the STEP-HFpEF Program Discontinuation of Beta-Blocker Therapy after
Description
However, about half of the patients who take these drugs stop within a year because of unwanted side effects
doi: 10.1016/j.cell.2021.12.016
The use of GLP-1 agonists in children under 12 years of age should be considered on a case-by-case basis due to limited data and the absence of FDA approval
Follow the injection instructions carefully to minimize irritation, clean the injection site before use, and avoid areas with scars or moles
